German Diabetes Center (DDZ)
Düsseldorf, 40225, Germany
NCT Number: NCT07389005
The goal of this clinical trial is to find out whether exercising at the right time of day, based on a person's natural body clock, leads to greater health benefits in people living with prediabetes. The main question it aims to answer is whether doing a single session of exercise in the morning or in the evening affects how the body handles sugar differently in adults with prediabetes who have an extreme natural body clock. This will be done by comparing three conditions (no-exercise, morning exercise, and evening exercise) within the same participant. Each condition will be tested on a different day, with at least 14 days between the test days. During the no-exercise test days, participants will come to the study centre and will only be allowed to do sedentary activities (e.g. office work, reading, or screen time). During the morning exercise test days, participants will perform an exercise session at 9:00 am that involves short periods of very hard effort followed by short rest periods. Whereas for the evening exercise test days, the same type of exercise will be performed at 5:00 pm.
Trial opening soon.
Get Notified19 year–75 year
All sexes
Interventional
Not applicable
Düsseldorf, 40225, Germany
Chronotype refers to an individual's circadian preferences for being active and fully functional at certain times of the day. Using validated questionnaires, individual's chronotype can be categorized to either a morning (lark), evening (owl), or intermediate (neutral) chronotypes. Individuals with morning chronotype wake up and go to bed early. Therefore, their calorie distribution as well as peak mental and physical performances predominantly occur earlier in the day. This is in contrast with individuals with evening chronotype that wake up and go to bed late, resulting in most of their calorie consumption happens later in the day. They are also more active and alert in the evening. Growing evidence has shown that late afternoon or evening exercise is better than morning exercise for blood glucose control in individuals with type 2 diabetes (T2D) or those at risk of T2D. In men with T2D, two weeks of high-intensity interval training (HIIT) reduced continuous glucose monitor (CGM)-based glucose concentration when performed in the afternoon than in the morning. This finding was further supported by a retrospective study involving men at risk for or T2D that found afternoon exercise led to superior peripheral insulin sensitivity, insulin-mediated suppression of adipose tissue lipolysis, and fasting plasma glucose. Interestingly, in a recently published crossover trial involving men and women, with and without T2D, no difference was observed in 24-hour glucose profile assessed using CGM across all cohorts (including gender and diabetes status) between morning and evening exercise. However, morning exercise increased post-exercise blood glucose levels during the two hours recovery period in both men and women with T2D, which was not observed following the evening exercise. It is important to note that all the above-mentioned studies are either excluding individuals with extreme chronotype or the chronotype of the participants was not clearly reported. This limitation raises an important research question: Do people living with extreme chronotype respond differently to timed exercise? Therefore, in this study, it is hypothesize that people living with prediabetes and extreme chronotype will gain superior metabolic benefits when the timing of exercise is aligned with their chronotype. To test this, a randomized controlled cross-over study is conducted in which participants are subjected to three conditions that are no-exercise, morning exercise, and evening exercise. The main outcome is insulin sensitivity determined by a 2-step hyperinsulinemic-euglycemic clamp.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An acute exercise bout of cycling performed in the morning at 9 AM
No exercise
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on insulin sensitivity assessed using insulin sensitivity index (reported as M-value: mg x kg-1 x min-1) during an hyperinsulinemic-euglycemic clamp
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on skeletal muscle mitochondrial respiration (pmol/mg/s) measured with high resolution respirometry
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on quantified DNA measured with quantitative polymerase chain reaction (qPCR)
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on adipose tissue mitochondrial respiration (pmol/mg/s) measured with high resolution respirometry
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on quantified DNA measured with quantitative polymerase chain reaction (qPCR)
Time frame: Post-dinner on exercise day
Effect of timed exercise on hepatic glycogen content, expressed in millimoles per liter (mmol/L) of liver tissue
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on serum glucose levels (mg/dL) determined from venous blood draws
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on serum free fatty acid levels (mmol/L) determined from venous blood draws
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on serum triglycerides (mg/dL) determined from venous blood draws
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on serum cholesterol (mg/dL) determined from venous blood draws
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on serum insulin levels (uIU/mL) determined from venous blood draws
Time frame: 12 to 24 hours post-exercise intervention
Effect of timed exercise on resting energy expenditure, expressed in kilocalories per day (kcal/day)
Time frame: The nighttime of exercise intervention day
Effect of timed exercise on sleep duration, efficiency, and fragmentation are measured objectively from the actighrapy device
Time frame: Baseline assessment
To assess the difference in liver lipid content in percentage (%) between morning versus evening chronotypes
Time frame: Baseline assessment
To assess the difference in skeletal muscle lipid content in percentage (%) between morning versus evening chronotypes
Time frame: Baseline assessment
To assess the difference in body composition between morning versus evening chronotypes
Time frame: Baseline assessment
To assess the difference in maximal aerobic capacity (VO₂max) between morning versus evening chronotypes
Time frame: Baseline assessment
To assess the difference in subjective sleep quality between morning versus evening chronotypes. Total score range of 1 to 21, higher scores indicating poorer sleep quality
Time frame: Baseline assessment
To assess the difference in level of sleepiness between morning versus evening chronotypes. On a 7-point scale, 1 representing feeling alert and 7 indicating being almost in reverie
Time frame: Baseline assessment
To assess the difference in consumption frequency of specific foods or food groups (expressed as times per week) between morning versus evening chronotypes
Time frame: Baseline assessment
To assess the difference in hedonic hunger between morning versus evening. Mean score of 15 items rated on a 5-point Likert scale (range 1-5). Higher scores indicate greater psychological responsiveness to food cues
Time frame: Baseline assessment
To assess the difference in self-reported craving strength between morning versus evening chronotypes. A numeric rating scale ranges from 0 to 10. Higher scores indicate stronger food cravings
Time frame: Baseline assessment
To assess subjective physical activity levels (low, moderate, high expressed as MET-minutes/week) between morning versus evening chronotypes
Time frame: Baseline assessment
To assess the difference in cognitive performance between morning versus evening chronotypes. Performance is assessed using commission errors (incorrect responses to no-go stimuli), omission errors (missed responses to go stimuli), mean reaction time, and reaction time variability, with higher error rates and greater reaction time variability indicating poorer sustained attention and inhibitory control
Time frame: Baseline assessment
To assess the difference in cognitive performance between morning versus evening chronotypes. Performance is assessed using mean reaction time, number of lapses (reaction times ≥500 ms), and fastest 10% reaction times, with slower reaction times and more lapses indicating reduced vigilant attention and alertness.
Time frame: Baseline assessment
To assess the difference in well-being between morning versus evening chronotypes. Scores range from 0 to 25 with higher scores indicating better well-being and psychological health
Time frame: Baseline assessment
To assess the difference in mental health between morning versus evening chronotypes. A 9-item self-report questionnaire assessing depressive symptoms over the past two weeks, scored from 0 to 27 with higher scores indicating greater severity of depressive symptoms
Time frame: Baseline assessment
To assess the difference in quality of life between morning versus evening chronotypes. A self-report questionnaire assessing health-related quality of life across eight domains-physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health-with scores transformed to a 0-100 scale, where higher scores indicate better health and functioning
Contact information is provided by the study sponsor or research team.
Friedrich C. Jassil, PhD
CONTACT
Patrick Schrauwen, PhD
CONTACT
German Diabetes Center
Other
Timed Exercise in Prediabetes With Extreme Chronotype
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06976307
Behavior, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT07372729
Body Weight, Borderline Dyslipidemia
Beijing, Beijing Municipality, China
View Trial DetailsNCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT04931836
Behavior, Body Weight
Minneapolis, Minnesota, United States
View Trial Details